Table 3

Association of markers with baseline disease activity

Serum protein and RNA markers
Serum IL-6Serum sIL-6RIL-6R 217489_s_atIL-6ST 234967_at
End pointAMBITIONRADIATEPooled DMARD-IRAMBITIONRADIATEPooled DMARD-IRRADIATERADIATE
DAS28
 N48032222865774232620217217
 β0.2090.2570.201–0.0070.0750.0540.109–0.04
 r20.0510.0720.04400.0060.0030.0130.002
 p<0.0001<0.0001<0.00010.84780.10180.00440.090.54
TJC
 N48132723055804282642217217
 β–0.1861.4550.138–0.1541.280.0540.271.276
 r200.009000.007000.007
 p0.77420.09380.66110.79670.08890.85580.790.2140
SJC
 N48132723055804282642217217
 β0.2471.4210.813–0.679–0.0690.52–0.8640.218
 r200.0180.0060.00400.0020.0080
 p0.62790.01580.00030.14240.89380.0130.19500.7440
ESR
 N48132722995804282635217217
 β0.190.1720.1510.039–0.0030.0230.164–0.132
 r20.0880.0910.0550.00400.0010.0820.053
 p<0.0001<0.0001<0.00010.1320.91580.0672<0.00010.0007
CRP
 N48132723055804282642217217
 β0.3630.4290.350.0070.0190.0190.228–0.145
 r20.2880.3580.30900.0010.0010.0890.036
 p<0.0001<0.0001<0.00010.81030.59350.1242<0.00010.005
HAQ
 N48032421655794252465217217
 β0.0850.1450.0840.0020.0740.0240.048–0.103
 r20.0190.0620.01800.0160.0020.0070.031
 p0.0022<0.0001<0.00010.9330.00890.05040.220.009
DNA markers
TiersGeneChrSNPPopulationMAFEnd pointnβSERaw PFDR P
1IL-6R1rs1386821White0.17HAQ7080.1350.0410.0010.18
All0.15HAQ8450.1180.0400.0040.52
3TOLLIP11rs5743899All0.22ESR8930.150.034491.5E-050.046
RUNX121rs2252585All0.32ESR9050.12090.028843.0E-050.046
IL-1RAPL123rs12559028All0.49SJC9052.1820.53494.9E-050.050
rs5943618All0.44SJC9052.270.54243.1E-050.046
rs4829239All0.38SJC9052.3210.55923.6E-050.046
rs5927671All0.45ESR8970.11810.028533.8E-050.046
  • All results for serum markers are shown. For RNA, the probe sets within each gene were strongly correlated. One probe set each in IL-6R and IL-6ST is shown. For DNA, only associations with raw p<0.01 (tier 1) and FDR ps<0.05 (tiers 2 and 3) were shown. FDR was calculated within the population (white or all) and within the tier.

  • β, regression coefficient, representing the difference in the end point corresponding to SD in marker value; Chr, chromosome; CRP, C reactive protein; DAS28, Disease Activity Score using 28 joints; DMARD, disease-modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; IL-6ST, IL-6 signal transducer; IR, inadequate responder; MAF, minor allele frequency; MTX, methotrexate; SJC, swollen joint count; TCZ, tocilizumab; TJC, tender joint count.